The Toddler Milk Intervention Trial (ToMI), sponsored by Société des Produits Nestlé, aims to evaluate the impact of varying protein content in young-child formulas on growth and obesity risk in children aged 11.5 to 13.5 months. Given the increasing global concern over childhood obesity, this trial addresses a significant market need for nutritional products that promote healthy growth. The results could enhance Nestlé's portfolio in pediatric nutrition, potentially leading to competitive advantages in the infant formula market. The study's completion in 2024 positions Nestlé to leverage findings for product development and marketing strategies targeting health-conscious parents. The trial's multicenter design across Germany and Spain may also facilitate broader European market penetration.